ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A comment.

Barrett, Christopher D; Moore, Hunter B; Yaffe, Michael B; Moore, Ernest E

Barrett, Christopher D; Moore, Hunter B; Yaffe, Michael B; Moore, Ernest E.

Barrett CD; Departments of Biological Engineering and Biology, Center for Precision Cancer Medicine, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Moore HB; Division of Acute Care Surgery, Trauma and Surgical Critical Care, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Yaffe MB; Department of Surgery, University of Colorado Denver, Aurora, CO, USA.
Moore EE; Departments of Biological Engineering and Biology, Center for Precision Cancer Medicine, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.

J Thromb Haemost ; 18(8): 2060-2063, 2020 08.

Article in English | MEDLINE | ID: covidwho-72069

Subject(s)

Betacoronavirus; Coronavirus Infections; Pandemics; Pneumonia, Viral; COVID-19; Humans; SARS-CoV-2

Keywords

COVID-19; International Society on Thrombosis and Haemostasis (ISTH); acute respiratory distress syndrome (ARDS); anticoagulation; disseminated intravascular coagulation

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus Limits: Humans Language: English Journal: J Thromb Haemost Journal subject: Hematology Year: 2020 Document Type: Article Affiliation country: Jth.14860

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google